A complete application in a minute — tailored resume and cover letter, ready to send.
Aphios Corporation, a clinical-stage biotechnology company, seeks a PhD-level Scientist / Senior Scientist for a flexible part-time or consulting role focused on mammalian cell culture and cell-based assay development in the Boston/Cambridge area.
The successful candidate will establish, optimize, and conduct an in vitro anti-nausea assay using recombinant stomach-derived cells, alongside supporting GLP-1 and Alzheimer’s disease programs with various signaling, cytokine, and cytotoxicity studies.
Aphios Corporation, a clinical-stage biotechnology company, is seeking an experienced PhD-level Scientist / Senior Scientist with strong hands-on expertise in mammalian cell culture and cell-based assay development.
We are particularly interested in experienced biotechnology/pharmaceutical scientists seeking a flexible part-time or consulting role, including senior scientists transitioning from full-time industry careers, as well as experienced academic research scientists in the Boston/Cambridge scientific community who would welcome the opportunity to contribute directly to therapeutic development.
This is not primarily a management position. We are looking for a scientist who still enjoys experimental design, hands-on laboratory work, troubleshooting, data interpretation, and scientific problem-solving at the bench.
The scientist’s initial responsibility will be to establish, optimize, and conduct an in vitro anti-nausea assay using recombinant stomach-derived cells, including:
Substantially in parallel, the scientist will contribute to in vitro research supporting Aphios’ GLP-1 and Alzheimer’s disease programs, potentially including assays involving:
This position may be particularly attractive to a senior industry scientist seeking to remain scientifically active on a flexible basis, or an experienced academic scientist interested in applying deep laboratory expertise directly to therapeutic development.
Rather than supervising a large research organization, the successful candidate will have the opportunity to personally establish important assays, generate and interpret data, and influence the scientific direction of multiple development programs.
The position is structured as part-time / consulting, with flexibility based on experience, availability, and program requirements.
Aphios is advancing a diversified therapeutic portfolio that includes a planned Phase III clinical program for Zindol®, planned Phase IIb programs in opioid addiction and chronic epilepsy, and additional therapeutic programs progressing through IND-enabling development.